Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2018 Filed Mar 2, 2018 22:17 UTC |
FOLETTA MARK GEVP & Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $11.19 | $0.00 |
DisclosureSEC source: 0001209191-18-015828 · doc4.xml · derivative · entry 1 FOLETTA MARK G · CIK 0001236389 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2028-02-29 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 3/01/2018; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 3/01/2018. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:19 UTC |
Jolly DouglasEVP, Research & Pharm Devel
|
GrantEmployee Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $11.19 | $0.00 |
DisclosureSEC source: 0001209191-18-015835 · doc4.xml · derivative · entry 1 Jolly Douglas · CIK 0001701643 · EVP, Research & Pharm Devel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-02-29 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 3/01/2018; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 3/01/2018. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:15 UTC |
Duvall Martin JDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $11.19 | $0.00 |
DisclosureSEC source: 0001209191-18-015824 · doc4.xml · derivative · entry 1 Duvall Martin J · CIK 0001313390 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2028-02-29 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 3/01/2018; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 3/01/2018. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:13 UTC |
Das AshaSVP & Chief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $11.19 | $0.00 |
DisclosureSEC source: 0001209191-18-015819 · doc4.xml · derivative · entry 1 Das Asha · CIK 0001701647 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2028-02-29 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 3/01/2018; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 3/01/2018. Read SEC document |
| December 08, 2017 Filed Dec 14, 2017 20:51 UTC |
GRUBER HARRY EDirector · President, Research & Devel
|
OtherCommon Stock | 2,500 | $8.50 | $21,250.00 |
DisclosureSEC source: 0001209191-17-065787 · doc4.xml · nonDerivative · entry 1 GRUBER HARRY E · CIK 0001054917 · Director · President, Research & Devel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 2,500 shares by the Reporting Person on December 8, 2017 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 08, 2017 Filed Dec 15, 2017 02:07 UTC |
FOLETTA MARK GEVP & Chief Financial Officer
|
OtherCommon Stock | 2,500 | $8.50 | $21,250.00 |
DisclosureSEC source: 0001209191-17-065792 · doc4.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 2,500 shares by the Reporting Person on December 8, 2017 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 08, 2017 Filed Dec 15, 2017 02:10 UTC |
Das AshaSVP & Chief Medical Officer
|
OtherCommon Stock | 2,500 | $8.50 | $21,250.00 |
DisclosureSEC source: 0001209191-17-065793 · doc4.xml · nonDerivative · entry 1 Das Asha · CIK 0001701647 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 2,500 shares by the Reporting Person on December 8, 2017 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 08, 2017 Filed Dec 15, 2017 02:02 UTC |
Duvall Martin JDirector · Chief Executive Officer
|
OtherCommon Stock | 2,500 | $8.50 | $21,250.00 |
DisclosureSEC source: 0001209191-17-065788 · doc4.xml · nonDerivative · entry 1 Duvall Martin J · CIK 0001313390 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,071 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 2,500 shares by the Reporting Person on December 8, 2017 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 08, 2017 Filed Dec 15, 2017 01:46 UTC |
Jolly DouglasEVP, Research & Pharm Devel
|
OtherCommon Stock | 739 | $8.50 | $6,281.50 |
DisclosureSEC source: 0001209191-17-065786 · doc4.xml · nonDerivative · entry 1 Jolly Douglas · CIK 0001701643 · EVP, Research & Pharm Devel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 392,043 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 739 shares by the Reporting Person on December 8, 2017 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 26, 2017 Filed May 31, 2017 21:10 UTC |
GRUBER HARRY EDirector · President, Research & Devel
|
GrantEmployee Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $16.32 | $0.00 |
DisclosureSEC source: 0001209191-17-036622 · doc4.xml · derivative · entry 1 GRUBER HARRY E · CIK 0001054917 · Director · President, Research & Devel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-05-25 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 5/26/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 5/26/2017. Read SEC document |
| May 26, 2017 Filed Jun 1, 2017 01:13 UTC |
Jolly DouglasEVP, Research & Pharm Devel
|
GrantEmployee Stock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $16.32 | $0.00 |
DisclosureSEC source: 0001209191-17-036624 · doc4.xml · derivative · entry 1 Jolly Douglas · CIK 0001701643 · EVP, Research & Pharm Devel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2027-05-25 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 5/26/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 5/26/2017. Read SEC document |
| May 26, 2017 Filed Jun 1, 2017 01:12 UTC |
Das AshaSVP & Chief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 130,000 | $0.00 Strike: $16.32 | $0.00 |
DisclosureSEC source: 0001209191-17-036623 · doc4.xml · derivative · entry 1 Das Asha · CIK 0001701647 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2027-05-25 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 5/26/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 5/26/2017. Read SEC document |
| May 26, 2017 Filed Jun 1, 2017 01:08 UTC |
FOLETTA MARK GEVP & Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $16.32 | $0.00 |
DisclosureSEC source: 0001209191-17-036621 · doc4.xml · derivative · entry 1 FOLETTA MARK G · CIK 0001236389 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2027-05-25 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 5/26/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 5/26/2017. Read SEC document |
| May 26, 2017 Filed Jun 1, 2017 00:34 UTC |
Duvall Martin JDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 285,000 | $0.00 Strike: $16.32 | $0.00 |
DisclosureSEC source: 0001209191-17-036617 · doc4.xml · derivative · entry 1 Duvall Martin J · CIK 0001313390 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,000 Underlying: Common Stock · 285,000 shares Expires 2027-05-25 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 5/26/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 5/26/2017. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 17:41 UTC |
GRUBER HARRY EDirector · President, Research & Devel
|
PurchaseCommon Stock | 25,000 | $10.00 | $250,000.00 |
DisclosureSEC source: 0001209191-17-027909 · doc4.xml · nonDerivative · entry 1 GRUBER HARRY E · CIK 0001054917 · Director · President, Research & Devel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Harry Edward Gruber and Joan Diane Cunningham Trust, dated 7/12/1988 Disclosed balance after: 417,753 F1 · kind: The shares were purchased at the Issuer's initial public offering. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:44 UTC |
Das AshaSVP & Chief Medical Officer
|
PurchaseCommon Stock | 2,500 | $10.00 | $25,000.00 |
DisclosureSEC source: 0001209191-17-027911 · doc4.xml · nonDerivative · entry 1 Das Asha · CIK 0001701647 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · kind: The shares were purchased at the Issuer's initial public offering. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:42 UTC |
FOLETTA MARK GEVP & Chief Financial Officer
|
PurchaseCommon Stock | 5,000 | $10.00 | $50,000.00 |
DisclosureSEC source: 0001209191-17-027910 · doc4.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · kind: The shares were purchased at the Issuer's initial public offering. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:37 UTC |
BERGER FRANKLIN MDirector
|
OtherCommon Stock | 25,335 | $10.00 | $253,350.00 |
DisclosureSEC source: 0001209191-17-027907 · doc4.xml · nonDerivative · entry 1 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,335 F1 · kind: Represents the conversion of an outstanding convertible promissory note in the principal amount of $250,000, plus $3,356.16 accrued interest, into shares of the Issuer's common stock upon closing of the Issuer's initial public offering at a conversion price of $10.00 per share. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:39 UTC |
Duvall Martin JDirector · Chief Executive Officer
|
OtherCommon Stock | 3,571 | $10.00 | $35,710.00 |
DisclosureSEC source: 0001209191-17-027908 · doc4.xml · nonDerivative · entry 1 Duvall Martin J · CIK 0001313390 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,571 F1 · kind: Represents the conversion of outstanding convertible promissory notes in the aggregate principal amount of $35,000, plus an aggregate of $714.39 accrued interest, into shares of the Issuer's common stock upon closing of the Issuer's initial public offering at a conversion price of $10.00 per share. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:34 UTC |
SCHIMMEL PAULDirector
|
ConversionSeries G Preferred Stock · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027905 · doc4.xml · derivative · entry 9 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Schimmel Revocable Trust Paul R. Schimmel, Trustee Cleo Schimmel, Trustee U/A dtd 9/6/2000 Disclosed balance after: 0 Underlying: Common Stock · 3,623 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. F1 · derivative.exercise_date: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. F1 · derivative.expiration_date: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:34 UTC |
SCHIMMEL PAULDirector
|
ConversionSeries G Preferred Stock · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027905 · doc4.xml · derivative · entry 8 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Paul Schimmel Prototype PSP Paul R. Schimmel, TTEE U/A dtd 01/01/1999 FBO Paul Schimmel Disclosed balance after: 0 Underlying: Common Stock · 3,623 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. F1 · derivative.exercise_date: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. F1 · derivative.expiration_date: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:34 UTC |
SCHIMMEL PAULDirector
|
ConversionSeries F Preferred Stock · Derivative | 28,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027905 · doc4.xml · derivative · entry 7 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By NFS/FMTC FBO Paul Schimmel Rollover IRA Disclosed balance after: 0 Underlying: Common Stock · 4,117 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. F1 · derivative.exercise_date: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. F1 · derivative.expiration_date: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:34 UTC |
SCHIMMEL PAULDirector
|
ConversionSeries H Preferred Stock · Derivative | 161,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027905 · doc4.xml · derivative · entry 6 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,464 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. F1 · derivative.exercise_date: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. F1 · derivative.expiration_date: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:34 UTC |
SCHIMMEL PAULDirector
|
PurchaseCommon Stock | 10,000 | $10.00 | $100,000.00 |
DisclosureSEC source: 0001209191-17-027905 · doc4.xml · nonDerivative · entry 5 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Schimmel Revocable Trust Paul R. Schimmel, Trustee Cleo Schimmel, Trustee U/A dtd 9/6/2000 Disclosed balance after: 13,623 F2 · kind: The shares were purchased at the Issuer's initial public offering. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:34 UTC |
SCHIMMEL PAULDirector
|
ConversionCommon Stock | 3,623 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-027905 · doc4.xml · nonDerivative · entry 4 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Schimmel Revocable Trust Paul R. Schimmel, Trustee Cleo Schimmel, Trustee U/A dtd 9/6/2000 Disclosed balance after: 3,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:34 UTC |
SCHIMMEL PAULDirector
|
ConversionCommon Stock | 3,623 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-027905 · doc4.xml · nonDerivative · entry 3 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Paul Schimmel Prototype PSP Paul R. Schimmel, TTEE U/A dtd 01/01/1999 FBO Paul Schimmel Disclosed balance after: 3,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:34 UTC |
SCHIMMEL PAULDirector
|
ConversionCommon Stock | 4,117 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-027905 · doc4.xml · nonDerivative · entry 2 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By NFS/FMTC FBO Paul Schimmel Rollover IRA Disclosed balance after: 4,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:34 UTC |
SCHIMMEL PAULDirector
|
ConversionCommon Stock | 23,464 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-027905 · doc4.xml · nonDerivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-6.9 basis. The shares have no expiration date. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:28 UTC |
Hasnain FaheemDirector
|
PurchaseCommon Stock | 100,000 | $10.00 | $1,000,000.00 |
DisclosureSEC source: 0001209191-17-027904 · doc4.xml · nonDerivative · entry 2 Hasnain Faheem · CIK 0001352620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Faheem Hasnain and Marie Hasnain Co-Trustees of the Hasnain Revocable Trust,dtd February 19, 2010 Disclosed balance after: 202,857 F2 · kind: The shares were purchased at the Issuer's initial public offering. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:28 UTC |
Hasnain FaheemDirector
|
OtherCommon Stock | 102,857 | $10.00 | $1,028,570.00 |
DisclosureSEC source: 0001209191-17-027904 · doc4.xml · nonDerivative · entry 1 Hasnain Faheem · CIK 0001352620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Faheem Hasnain and Marie Hasnain Co-Trustees of the Hasnain Revocable Trust,dtd February 19, 2010 Disclosed balance after: 102,857 F1 · kind: Represents the conversion of an outstanding convertible promissory note in the principal amount of $1,000,000, plus $28,575.34 accrued interest, into shares of the Issuer's common stock upon closing of the Issuer's initial public offering at a conversion price of $10.00 per share. Read SEC document |
| April 12, 2017 Filed Apr 12, 2017 21:00 UTC |
GRUBER HARRY EDirector · President, Research & Devel
|
GrantEmployee Stock Option (right to buy) · Derivative | 27,536 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026751 · doc4.xml · derivative · entry 1 GRUBER HARRY E · CIK 0001054917 · Director · President, Research & Devel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,536 Underlying: Common Stock · 27,536 shares Expires 2027-04-11 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 4/1/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 4/1/2017. Read SEC document |
| April 12, 2017 Filed Apr 12, 2017 20:55 UTC |
DARCY THOMAS EDirector · Executive Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 4,528 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026748 · doc4.xml · derivative · entry 1 DARCY THOMAS E · CIK 0001126910 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,528 Underlying: Common Stock · 4,528 shares Expires 2027-04-11 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 4/1/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 4/1/2017. Read SEC document |
| April 12, 2017 Filed Apr 12, 2017 21:06 UTC |
Parkinson David RossDirector
|
GrantStock Option (right to buy) · Derivative | 4,528 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026755 · doc4.xml · derivative · entry 1 Parkinson David Ross · CIK 0001451935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,528 Underlying: Common Stock · 4,528 shares Expires 2027-04-11 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 4/1/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 4/1/2017. Read SEC document |
| April 12, 2017 Filed Apr 13, 2017 01:09 UTC |
SCHIMMEL PAULDirector
|
GrantStock Option (right to buy) · Derivative | 4,528 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026757 · doc4.xml · derivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,528 Underlying: Common Stock · 4,528 shares Expires 2027-04-11 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 4/1/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 4/1/2017. Read SEC document |
| April 12, 2017 Filed Apr 13, 2017 01:08 UTC |
BERGER FRANKLIN MDirector
|
GrantStock Option (right to buy) · Derivative | 7,246 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026756 · doc4.xml · derivative · entry 1 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,246 Underlying: Common Stock · 7,246 shares Expires 2027-04-11 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 4/1/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 4/1/2017. Read SEC document |
| April 12, 2017 Filed Apr 13, 2017 01:05 UTC |
Kunkel Lori AnneDirector
|
GrantStock Option (right to buy) · Derivative | 4,528 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026754 · doc4.xml · derivative · entry 1 Kunkel Lori Anne · CIK 0001536368 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,528 Underlying: Common Stock · 4,528 shares Expires 2027-04-11 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 4/1/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 4/1/2017. Read SEC document |
| April 12, 2017 Filed Apr 13, 2017 01:04 UTC |
Jolly DouglasEVP, Research & Pharm Devel
|
GrantEmployee Stock Option (right to buy) · Derivative | 14,492 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026753 · doc4.xml · derivative · entry 1 Jolly Douglas · CIK 0001701643 · EVP, Research & Pharm Devel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,492 Underlying: Common Stock · 14,492 shares Expires 2027-04-11 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 4/1/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 4/1/2017. Read SEC document |
| April 12, 2017 Filed Apr 13, 2017 01:02 UTC |
Hasnain FaheemDirector
|
GrantStock Option (right to buy) · Derivative | 10,869 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026752 · doc4.xml · derivative · entry 1 Hasnain Faheem · CIK 0001352620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,869 Underlying: Common Stock · 10,869 shares Expires 2027-04-11 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 4/1/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 4/1/2017. Read SEC document |
| April 12, 2017 Filed Apr 13, 2017 00:59 UTC |
Duvall Martin JDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 46,739 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026750 · doc4.xml · derivative · entry 1 Duvall Martin J · CIK 0001313390 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,739 Underlying: Common Stock · 46,739 shares Expires 2027-04-11 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 4/1/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 4/1/2017. Read SEC document |
| April 12, 2017 Filed Apr 13, 2017 00:57 UTC |
Das AshaSVP & Chief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,246 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026749 · doc4.xml · derivative · entry 1 Das Asha · CIK 0001701647 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,246 Underlying: Common Stock · 7,246 shares Expires 2027-04-11 F1 · derivative.exercise_date: 1/4th of the shares vest one year after 4/1/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 4/1/2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.